• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病是墨西哥 COVID-19 患者死亡风险极高的一个非常重要的合并症。

Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.

机构信息

Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Tamaulipas, Mexico.

Cardiology Clinical Care, Centro Médico Pensiones, Yucatán, Mexico.

出版信息

Nephrology (Carlton). 2021 Mar;26(3):248-251. doi: 10.1111/nep.13827. Epub 2020 Nov 22.

DOI:10.1111/nep.13827
PMID:33184959
Abstract

Chronic kidney disease (CKD) is a recognized public health problem and key determinant of poor health outcomes. In Mexico, this condition has been associated with high and significant risk of death in COVID-19 patients; however, not enough attention has been given to the vulnerable population as the increasing numbers and fatality rates suggest. This study evaluated the effect of interaction between CKD condition and other risk factors (sex, diabetes, hypertension and obesity) on the survival rate of positive patients for COVID-19 in Mexico. The results from this study support that CKD patients is a population at high risk for mortality for COVID-19 and that COVID-19 positive inpatients with CKD and diabetes are highly vulnerable to death.

摘要

慢性肾脏病(CKD)是一个公认的公共卫生问题,也是健康状况不佳的关键决定因素。在墨西哥,这种情况与 COVID-19 患者的高死亡率和显著风险相关;然而,由于不断增加的病例数和死亡率表明,弱势群体并没有得到足够的关注。本研究评估了 CKD 状况与其他危险因素(性别、糖尿病、高血压和肥胖)之间的相互作用对墨西哥 COVID-19 阳性患者生存率的影响。本研究结果表明,CKD 患者是 COVID-19 高死亡率人群,并且 CKD 和糖尿病合并 COVID-19 的住院患者极易死亡。

相似文献

1
Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.慢性肾脏病是墨西哥 COVID-19 患者死亡风险极高的一个非常重要的合并症。
Nephrology (Carlton). 2021 Mar;26(3):248-251. doi: 10.1111/nep.13827. Epub 2020 Nov 22.
2
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
3
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.土耳其全国性分析:与无肾病患者相比,慢性肾脏病、血液透析和肾移植患者 COVID-19 感染的死亡率分析。
Nephrol Dial Transplant. 2020 Dec 4;35(12):2083-2095. doi: 10.1093/ndt/gfaa271.
4
COVID-19 and chronic renal disease: clinical characteristics and prognosis.COVID-19 与慢性肾脏病:临床特征与预后。
QJM. 2020 Nov 1;113(11):799-805. doi: 10.1093/qjmed/hcaa258.
5
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
6
SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results.西班牙 CKD-5D 患者队列中 SARS-CoV-2 感染:患病率、临床特征、结局和解除隔离结果。
Blood Purif. 2021;50(4-5):531-538. doi: 10.1159/000510557. Epub 2020 Dec 22.
7
Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.慢性肾脏病或急性肾损伤与 COVID-19 患者临床结局的关联。
J Korean Med Sci. 2020 Dec 28;35(50):e434. doi: 10.3346/jkms.2020.35.e434.
8
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis.慢性肾脏病患者中新冠病毒病的发病率及转归:一项系统评价和荟萃分析
Am J Kidney Dis. 2021 Dec;78(6):804-815. doi: 10.1053/j.ajkd.2021.07.003. Epub 2021 Aug 5.
9
COVID-19 in children with chronic kidney disease: findings from the UK renal registry.慢性肾脏病患儿的新型冠状病毒肺炎:来自英国肾脏登记处的发现
Arch Dis Child. 2021 Mar;106(3):e16. doi: 10.1136/archdischild-2020-319903. Epub 2020 Jul 24.
10
Coronavirus Disease 2019 and Chronic Kidney Disease - A Clinical Observational Study.新型冠状病毒肺炎与慢性肾脏病的临床观察研究。
Saudi J Kidney Dis Transpl. 2021 May-Jun;32(3):744-753. doi: 10.4103/1319-2442.336770.

引用本文的文献

1
COVID-19 Infection in Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease Patients: Progression of Kidney Disease.常染色体显性多囊肾病和慢性肾病患者的新型冠状病毒肺炎感染:肾病进展
Biomedicines. 2024 Jun 12;12(6):1301. doi: 10.3390/biomedicines12061301.
2
An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study.阿联酋迪拜与 COVID-19 疾病严重程度相关的非传染性疾病和危险因素评估:一项观察性回顾性研究。
Int J Environ Res Public Health. 2022 Nov 3;19(21):14381. doi: 10.3390/ijerph192114381.
3
Mortality and Quality of Life with Chronic Kidney Disease: A Five-Year Cohort Study with a Sample Initially Receiving Peritoneal Dialysis.
慢性肾脏病的死亡率与生活质量:一项针对初始接受腹膜透析样本的五年队列研究
Healthcare (Basel). 2022 Oct 28;10(11):2144. doi: 10.3390/healthcare10112144.
4
Diabetes and Mortality among Patients with Chronic Kidney Disease and COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.慢性肾脏病合并新型冠状病毒肺炎患者的糖尿病与死亡率:一项系统评价、荟萃分析和Meta回归分析
Indian J Nephrol. 2022 Jul-Aug;32(4):327-333. doi: 10.4103/ijn.ijn_293_21. Epub 2022 May 20.
5
Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis.确诊 COVID-19 患者中慢性肾脏病与死亡率的相关性。
PeerJ. 2022 Jun 14;10:e13437. doi: 10.7717/peerj.13437. eCollection 2022.
6
Challenges for Peritoneal Dialysis Centers Before and During the COVID-19 Pandemic in Mexico.墨西哥 COVID-19 大流行前后腹膜透析中心面临的挑战。
Arch Med Res. 2022 Jun;53(4):431-440. doi: 10.1016/j.arcmed.2022.04.005. Epub 2022 Apr 29.
7
COVID-19 and chronic kidney disease: an updated overview of reviews.COVID-19 与慢性肾脏病:系统评价的更新概述。
J Nephrol. 2022 Jan;35(1):69-85. doi: 10.1007/s40620-021-01206-8. Epub 2022 Jan 11.
8
The Impact of COVID-19 on Patients With ADPKD.2019年冠状病毒病对常染色体显性多囊肾病患者的影响
Can J Kidney Health Dis. 2021 Nov 10;8:20543581211056479. doi: 10.1177/20543581211056479. eCollection 2021.
9
Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean.COVID-19 住院患者的临床结局以及基于循证的药理学管理在哥伦比亚加勒比地区降低了死亡率。
J Infect Public Health. 2021 Jun;14(6):696-701. doi: 10.1016/j.jiph.2021.02.013. Epub 2021 Mar 6.
10
Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.肥胖是墨西哥新冠肺炎患者短期死亡率和不良结局的一个重要风险因素:一项全国性观察性研究。
Epidemiol Infect. 2021 Apr 29;149:e109. doi: 10.1017/S0950268821001023.